FDA's Makary Discusses Trump's Executive Order to Improve Access to Psychedelics
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: Bloomberg
Discussion on Executive Order: Dr. Marty Makary discusses President Trump's Executive Order aimed at accelerating research and access to psychedelics, highlighting its potential impact on mental health treatment.
Significance of the Moment: He describes the initiative as a historic moment, emphasizing the promising research surrounding psychedelics and their therapeutic applications.
Interview Context: The discussion takes place in an interview format with Romaine Bostick and Katie Greifeld on "The Close."
Source of Information: The insights are reported by Bloomberg, providing a platform for the conversation on this significant health policy development.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
